TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05721261: Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

Sponsor: Epineuron Technologies Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 110 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$1,826,000

Rescue Site Savings

+$1,195,200

Unlock Full NCT05721261 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05721261 Rescue Dossier →